Custom Biopharmaceutical Manufacturing Facilities To Boost Single-Use Bioprocessing Industry

CHICAGO - Nov. 21, 2018 - PRLog -- The introduction of advanced integrated equipment will transform the global single-use bioprocessing market.

Arizton's recent market research report on the global single-use bioprocessing market provides comprehensive industry analysis, trend forecasts, and competitive analysis. The research study segments the market by product (simple & peripheral devices and single-use bioprocessing equipment), by application (filtration, storage & transfer, cell culture, mixing, and purification), by end-users (biopharmaceuticals manufacturing companies, CMOs, and R&D companies & research institutes), by geography (North America, Europe, APAC, Latin America, and MEA), and offers detailed competitive analysis.

The global single-use bioprocessing market is expected to generate revenues of around $7 billion by 2024, growing at a CAGR of over 14% during 2018-2024.

The exponential advancement in the life science industry and the increasing number of patients opting for biosimilars and biopharmaceuticals is driving the growth of the global single-use bioprocessing market.  The phenomenal performance of SUTs in various bioprocessing applications and the wider adoption at commercial scale manufacturing will augment the development of the global market over the next few years.

The top 3 drivers and trends positively impacting the market are discussed below:

Growing Demand for Flexible and Custom Biopharmaceutical Manufacturing Facilities

The rising demand for flexible and custom biopharmaceutical manufacturing facilities is propelling the growth of the global single-use bioprocessing market. The biopharmaceutical industry is experiencing dynamic changes with biopharmaceuticals go off-patent, the emergence of new treatments, and drug pipelines are becoming increasingly diverse in the market. The increasing focus of the healthcare industry to initiate reforms and provide quality patient care at affordable prices will boost revenues in the global single-use bioprocessing market. The increasing prevalence of rare and chronic diseases, growing focus on personalized medicine, localized manufacturing, and the ability to adapt quickly as per changing dynamics will drive the need for flexible manufacturing. The growing number of flexible manufacturing facilities will create lucrative opportunities for leading vendors in the market. The growing incorporation of SUTs and the implementation of SUB offers end-users flexibility in terms of scalability, production mode, mixing, and volumes in the market. The introduction of advanced integrated equipment will transform the global single-use bioprocessing market.

New Product Launches

The increasing focus on the development and launch new products will propel the development of the global single-use bioprocessing market. New product approvals/launches coupled with R&D activities help the vendors to expand their presence, enhance market growth, and sustain their position in the global market. The leading vendors are actively engaged in R&D activities and plan to launch innovative products. Companies such as Sartorius Stedim Biotech, Danaher (Pall), Merck KGaA, and Thermo Fisher Scientific are contributing a great deal in the global single-use bioprocessing market,  and will launch innovative products. The vendors are investing in the new products approvals from regulatory bodies, which in turn, will positively impact the global market during the forecast period. Some of the recent product launches in the market are New Mini Microcarrier Bioreactor for ambr high throughput system, Allegro STR 50 L bioreactor, ambr 250 high throughput (ht) bioreactor system for perfusion culture, Helium Integrity Test (HIT) system, Allegro Fully Automated, Single-Use Chromatography System, and StaxmAx clarification platform, etc. With the initiatives to get maximum product approvals vendors will try and gain larger global single-use bioprocessing market share of the next few years.

Request for your free sample today! (https://www.arizton.com/market-reports/single-use-bioproc...)

Technological Advancements/Improvements in Single-use Bioprocessing

The growing focus on technological advances and improvements is propelling the growth of the global single-use bioprocessing market. The development of several advanced and innovative single-use technology will help vendors gain a larger market share during the forecast period. The innovations in term of product design, production enhancement, and efficiency will fuel the growth of the market.The growing demand for biopharmaceuticals and biosimilars has encouraged many pharma and biotech companies to purchase several single-use systems and disposables. SUT has a wide range of application and use for different biomanufacturing processes such as filtration, upstream expression, mixing, purification, formulation, separations, and filling. The increasing availability of many products such as disposable filter cartridges, tangential flow filters, depth filters, tubing, and connectors suitable for downstream processing applications will transform the global single-use bioprocessing market.

The leading vendors in the market are Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher, GE Healthcare, and Avantor.

The complete overview of the latest market research report on the global single-use bioprocessing market (https://www.arizton.com/market-reports/single-use-bioproc...) by Arizton is now available.

The report also offers a detailed study of major trends, drivers, challenges, and also provides the market size and forecast for major geographical regions and key countries.